Chemed CorporationCHENYSE
Loading
Chemed operates two distinct healthcare businesses: VITAS Healthcare (approximately 80% of revenue), the nation's second-largest hospice provider serving ~19,000 patients daily across 14 states and Washington D.C., and Roto-Rooter (approximately 20% of revenue), a plumbing and drain cleaning franchise network with ~110 company-owned branches and 500+ franchisees. The company benefits from demographic tailwinds (aging population driving hospice utilization) and essential service demand (plumbing emergencies are non-discretionary), with strong cash generation supporting consistent capital returns.
VITAS generates predictable revenue through Medicare reimbursement (approximately 90% of hospice revenue), with rates indexed to inflation and adjusted annually. Profitability depends on managing length-of-stay (optimal 80-100 days), care level mix (routine home care highest margin at ~20% operating margin), and labor costs (nurses, aides). Roto-Rooter earns through service calls (average ticket $350-500 for drain cleaning, $2,000+ for water line replacement) with pricing power during emergencies, plus 4-6% franchise royalties. Both businesses have local market density advantages - VITAS achieves operational leverage through regional clustering of patients, while Roto-Rooter benefits from brand recognition and route density reducing truck roll costs.
VITAS average daily census (ADC) growth and admission trends - organic growth typically 2-4% annually driven by aging demographics and market share gains from smaller hospice providers
Medicare reimbursement rate updates - annual market basket increases (typically 2-3%) directly impact 80% of revenue, with potential policy changes to hospice payment reform
VITAS length-of-stay and acuity mix - longer stays improve profitability but very long stays (180+ days) trigger Medicare cap exposure; routine home care mix optimization drives margin
Roto-Rooter same-store sales growth and commercial demand - residential demand relatively stable, commercial segment more cyclical and tied to construction activity and business investment
Medicare hospice payment reform risk - CMS has proposed changes to the two-tier payment system and potential caps on routine home care lengths-of-stay, which could compress margins if very long-stay patients (currently ~8-10% of census) face reimbursement reductions
Hospice industry consolidation and competitive intensity - private equity-backed roll-ups and national chains (Encompass Health, Amedisys) increasing competition for referrals from hospitals and physicians, potentially pressuring admission growth and requiring higher sales/marketing spend
Labor availability and wage inflation in healthcare - nursing and home health aide shortages in tight labor markets increase costs and limit census growth capacity, with wage pressures typically exceeding Medicare reimbursement rate increases by 100-200 basis points
VITAS market share pressure from larger competitors (Kindred at Home, Compassus) in key geographies like California, Texas, and Florida, where referral relationships with hospital systems increasingly favor scale players with broader service offerings
Roto-Rooter brand erosion from digital lead generation platforms (HomeAdvisor, Angi) commoditizing plumbing services and increasing customer acquisition costs, while national competitors (ServiceMaster's American Home Shield, Neighborly brands) expand franchise footprints
Minimal financial leverage risk with debt/equity of 0.13 and $400M+ annual free cash flow providing substantial cushion - current $500M revolving credit facility largely undrawn
Pension obligations are modest (<$50M underfunded status) and well-managed, with frozen defined benefit plans representing minimal ongoing cash drag
low - VITAS hospice services are non-discretionary end-of-life care with 90% Medicare funding, making revenue largely recession-resistant and driven by demographic trends rather than economic cycles. Roto-Rooter's residential emergency services (60-65% of segment revenue) are also non-discretionary, though commercial plumbing and elective residential projects show moderate sensitivity to business investment and consumer confidence. Overall company revenue demonstrates <5% correlation to GDP fluctuations.
Rising rates have minimal direct impact given low leverage (0.13 debt/equity) and modest borrowing needs. However, higher rates can pressure valuation multiples for stable cash flow businesses, as investors compare yields to fixed income alternatives. VITAS expansion through tuck-in acquisitions (typical 6-8x EBITDA multiples for small hospice providers) becomes more expensive in higher rate environments. Roto-Rooter franchise expansion and housing turnover (which drives plumbing upgrades) show modest negative correlation to mortgage rates.
Minimal - 90% of VITAS revenue from Medicare (sovereign credit risk only), with remaining 10% from Medicare Advantage plans (investment-grade insurers) and private pay. Roto-Rooter operates on cash/credit card basis for residential services. No meaningful accounts receivable risk or exposure to consumer credit quality. Working capital requirements are low with negative cash conversion cycles in hospice business.
value/dividend - Attracts investors seeking defensive healthcare exposure with 1.0% dividend yield, consistent free cash flow generation (5.4% FCF yield), and modest growth (7-8% revenue CAGR). The combination of non-cyclical hospice revenue (80% of business) and essential services (Roto-Rooter) appeals to quality-focused value investors prioritizing capital returns and downside protection. Limited growth optionality versus high-growth healthcare peers, but superior cash generation and 24% ROE compensate through buybacks (company has reduced share count ~2% annually).
low - Beta estimated 0.7-0.8 reflecting defensive healthcare characteristics and stable Medicare reimbursement base. Stock typically trades in narrow range with occasional volatility around Medicare policy announcements or quarterly census misses. Hospice industry fundamentals (aging demographics, increasing utilization rates) provide earnings floor, while Roto-Rooter adds modest cyclical sensitivity. Historical volatility approximately 18-22% annualized, below healthcare sector average of 25-30%.